ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Morphine Sulfate Extended Release Tablets Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-2Z18035
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Morphine Sulfate Extended Release Tablets Market Research Report 2024
BUY CHAPTERS

Global Morphine Sulfate Extended Release Tablets Market Research Report 2024

Code: QYRE-Auto-2Z18035
Report
August 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Teva Pharmaceuticals
Mallinckrodt Pharmaceuticals
Purdue Pharma
NAPP PHARMACEUTICALS LIMITED
Vendors
Viatris
Allergan plc
Rhodes Pharmaceuticals
West Ward Pharmaceuticals

Morphine Sulfate Extended Release Tablets Market

The global Morphine Sulfate Extended Release Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Morphine Sulfate Extended Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Morphine Sulfate Extended Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Morphine Sulfate Extended Release Tablets include NAPP PHARMACEUTICALS LIMITED, Purdue Pharma, Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Viatris, Allergan, Rhodes Pharmaceuticals, West-Ward Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Morphine Sulfate Extended Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Morphine Sulfate Extended Release Tablets.
The Morphine Sulfate Extended Release Tablets market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Morphine Sulfate Extended Release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Morphine Sulfate Extended Release Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Morphine Sulfate Extended Release Tablets Market Report

Report Metric Details
Report Name Morphine Sulfate Extended Release Tablets Market
Segment by Type
  • 10mg
  • 30mg
  • 60mg
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company NAPP PHARMACEUTICALS LIMITED, Purdue Pharma, Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Viatris, Allergan, Rhodes Pharmaceuticals, West-Ward Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Morphine Sulfate Extended Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Morphine Sulfate Extended Release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Morphine Sulfate Extended Release Tablets Market report?

Ans: The main players in the Morphine Sulfate Extended Release Tablets Market are NAPP PHARMACEUTICALS LIMITED, Purdue Pharma, Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Viatris, Allergan, Rhodes Pharmaceuticals, West-Ward Pharmaceuticals

What are the Application segmentation covered in the Morphine Sulfate Extended Release Tablets Market report?

Ans: The Applications covered in the Morphine Sulfate Extended Release Tablets Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Morphine Sulfate Extended Release Tablets Market report?

Ans: The Types covered in the Morphine Sulfate Extended Release Tablets Market report are 10mg, 30mg, 60mg

Recommended Reports

Opioid Pain Therapies

Extended Release Tablets

Urinary and Analgesics

1 Morphine Sulfate Extended Release Tablets Market Overview
1.1 Product Definition
1.2 Morphine Sulfate Extended Release Tablets by Type
1.2.1 Global Morphine Sulfate Extended Release Tablets Market Value Comparison by Type (2024-2030)
1.2.2 10mg
1.2.3 30mg
1.2.4 60mg
1.3 Morphine Sulfate Extended Release Tablets by Application
1.3.1 Global Morphine Sulfate Extended Release Tablets Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Morphine Sulfate Extended Release Tablets Market Size Estimates and Forecasts
1.4.1 Global Morphine Sulfate Extended Release Tablets Revenue 2019-2030
1.4.2 Global Morphine Sulfate Extended Release Tablets Sales 2019-2030
1.4.3 Global Morphine Sulfate Extended Release Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Morphine Sulfate Extended Release Tablets Market Competition by Manufacturers
2.1 Global Morphine Sulfate Extended Release Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Morphine Sulfate Extended Release Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Morphine Sulfate Extended Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Morphine Sulfate Extended Release Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Morphine Sulfate Extended Release Tablets, Product Type & Application
2.7 Global Key Manufacturers of Morphine Sulfate Extended Release Tablets, Date of Enter into This Industry
2.8 Global Morphine Sulfate Extended Release Tablets Market Competitive Situation and Trends
2.8.1 Global Morphine Sulfate Extended Release Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Morphine Sulfate Extended Release Tablets Players Market Share by Revenue
2.8.3 Global Morphine Sulfate Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Morphine Sulfate Extended Release Tablets Market Scenario by Region
3.1 Global Morphine Sulfate Extended Release Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Morphine Sulfate Extended Release Tablets Sales by Region: 2019-2030
3.2.1 Global Morphine Sulfate Extended Release Tablets Sales by Region: 2019-2024
3.2.2 Global Morphine Sulfate Extended Release Tablets Sales by Region: 2025-2030
3.3 Global Morphine Sulfate Extended Release Tablets Revenue by Region: 2019-2030
3.3.1 Global Morphine Sulfate Extended Release Tablets Revenue by Region: 2019-2024
3.3.2 Global Morphine Sulfate Extended Release Tablets Revenue by Region: 2025-2030
3.4 North America Morphine Sulfate Extended Release Tablets Market Facts & Figures by Country
3.4.1 North America Morphine Sulfate Extended Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Morphine Sulfate Extended Release Tablets Sales by Country (2019-2030)
3.4.3 North America Morphine Sulfate Extended Release Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Morphine Sulfate Extended Release Tablets Market Facts & Figures by Country
3.5.1 Europe Morphine Sulfate Extended Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Morphine Sulfate Extended Release Tablets Sales by Country (2019-2030)
3.5.3 Europe Morphine Sulfate Extended Release Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Morphine Sulfate Extended Release Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Morphine Sulfate Extended Release Tablets Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Morphine Sulfate Extended Release Tablets Sales by Region (2019-2030)
3.6.3 Asia Pacific Morphine Sulfate Extended Release Tablets Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Morphine Sulfate Extended Release Tablets Market Facts & Figures by Country
3.7.1 Latin America Morphine Sulfate Extended Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Morphine Sulfate Extended Release Tablets Sales by Country (2019-2030)
3.7.3 Latin America Morphine Sulfate Extended Release Tablets Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Morphine Sulfate Extended Release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Morphine Sulfate Extended Release Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Morphine Sulfate Extended Release Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Morphine Sulfate Extended Release Tablets Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Morphine Sulfate Extended Release Tablets Sales by Type (2019-2030)
4.1.1 Global Morphine Sulfate Extended Release Tablets Sales by Type (2019-2024)
4.1.2 Global Morphine Sulfate Extended Release Tablets Sales by Type (2025-2030)
4.1.3 Global Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2019-2030)
4.2 Global Morphine Sulfate Extended Release Tablets Revenue by Type (2019-2030)
4.2.1 Global Morphine Sulfate Extended Release Tablets Revenue by Type (2019-2024)
4.2.2 Global Morphine Sulfate Extended Release Tablets Revenue by Type (2025-2030)
4.2.3 Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Morphine Sulfate Extended Release Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Morphine Sulfate Extended Release Tablets Sales by Application (2019-2030)
5.1.1 Global Morphine Sulfate Extended Release Tablets Sales by Application (2019-2024)
5.1.2 Global Morphine Sulfate Extended Release Tablets Sales by Application (2025-2030)
5.1.3 Global Morphine Sulfate Extended Release Tablets Sales Market Share by Application (2019-2030)
5.2 Global Morphine Sulfate Extended Release Tablets Revenue by Application (2019-2030)
5.2.1 Global Morphine Sulfate Extended Release Tablets Revenue by Application (2019-2024)
5.2.2 Global Morphine Sulfate Extended Release Tablets Revenue by Application (2025-2030)
5.2.3 Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Morphine Sulfate Extended Release Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 NAPP PHARMACEUTICALS LIMITED
6.1.1 NAPP PHARMACEUTICALS LIMITED Company Information
6.1.2 NAPP PHARMACEUTICALS LIMITED Description and Business Overview
6.1.3 NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Product Portfolio
6.1.5 NAPP PHARMACEUTICALS LIMITED Recent Developments/Updates
6.2 Purdue Pharma
6.2.1 Purdue Pharma Company Information
6.2.2 Purdue Pharma Description and Business Overview
6.2.3 Purdue Pharma Morphine Sulfate Extended Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Purdue Pharma Morphine Sulfate Extended Release Tablets Product Portfolio
6.2.5 Purdue Pharma Recent Developments/Updates
6.3 Mallinckrodt Pharmaceuticals
6.3.1 Mallinckrodt Pharmaceuticals Company Information
6.3.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.3.3 Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolio
6.3.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Company Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Viatris
6.5.1 Viatris Company Information
6.5.2 Viatris Description and Business Overview
6.5.3 Viatris Morphine Sulfate Extended Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Viatris Morphine Sulfate Extended Release Tablets Product Portfolio
6.5.5 Viatris Recent Developments/Updates
6.6 Allergan
6.6.1 Allergan Company Information
6.6.2 Allergan Description and Business Overview
6.6.3 Allergan Morphine Sulfate Extended Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Allergan Morphine Sulfate Extended Release Tablets Product Portfolio
6.6.5 Allergan Recent Developments/Updates
6.7 Rhodes Pharmaceuticals
6.7.1 Rhodes Pharmaceuticals Company Information
6.7.2 Rhodes Pharmaceuticals Description and Business Overview
6.7.3 Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolio
6.7.5 Rhodes Pharmaceuticals Recent Developments/Updates
6.8 West-Ward Pharmaceuticals
6.8.1 West-Ward Pharmaceuticals Company Information
6.8.2 West-Ward Pharmaceuticals Description and Business Overview
6.8.3 West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolio
6.8.5 West-Ward Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Morphine Sulfate Extended Release Tablets Industry Chain Analysis
7.2 Morphine Sulfate Extended Release Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Morphine Sulfate Extended Release Tablets Production Mode & Process
7.4 Morphine Sulfate Extended Release Tablets Sales and Marketing
7.4.1 Morphine Sulfate Extended Release Tablets Sales Channels
7.4.2 Morphine Sulfate Extended Release Tablets Distributors
7.5 Morphine Sulfate Extended Release Tablets Customers
8 Morphine Sulfate Extended Release Tablets Market Dynamics
8.1 Morphine Sulfate Extended Release Tablets Industry Trends
8.2 Morphine Sulfate Extended Release Tablets Market Drivers
8.3 Morphine Sulfate Extended Release Tablets Market Challenges
8.4 Morphine Sulfate Extended Release Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Teva Pharmaceuticals
Mallinckrodt Pharmaceuticals
Purdue Pharma
NAPP PHARMACEUTICALS LIMITED
Vendors
Viatris
Allergan plc
Rhodes Pharmaceuticals
West Ward Pharmaceuticals
List of Tables
 Table 1. Global Morphine Sulfate Extended Release Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Morphine Sulfate Extended Release Tablets Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Morphine Sulfate Extended Release Tablets Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Morphine Sulfate Extended Release Tablets Sales (Tons) of Key Manufacturers (2019-2024)
 Table 5. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Morphine Sulfate Extended Release Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Morphine Sulfate Extended Release Tablets Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Morphine Sulfate Extended Release Tablets Average Price (US$/Ton) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Morphine Sulfate Extended Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Morphine Sulfate Extended Release Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Morphine Sulfate Extended Release Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Morphine Sulfate Extended Release Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Morphine Sulfate Extended Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Morphine Sulfate Extended Release Tablets as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Morphine Sulfate Extended Release Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Morphine Sulfate Extended Release Tablets Sales by Region (2019-2024) & (Tons)
 Table 18. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Region (2019-2024)
 Table 19. Global Morphine Sulfate Extended Release Tablets Sales by Region (2025-2030) & (Tons)
 Table 20. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Region (2025-2030)
 Table 21. Global Morphine Sulfate Extended Release Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Region (2019-2024)
 Table 23. Global Morphine Sulfate Extended Release Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Region (2025-2030)
 Table 25. North America Morphine Sulfate Extended Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Morphine Sulfate Extended Release Tablets Sales by Country (2019-2024) & (Tons)
 Table 27. North America Morphine Sulfate Extended Release Tablets Sales by Country (2025-2030) & (Tons)
 Table 28. North America Morphine Sulfate Extended Release Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Morphine Sulfate Extended Release Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Morphine Sulfate Extended Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Morphine Sulfate Extended Release Tablets Sales by Country (2019-2024) & (Tons)
 Table 32. Europe Morphine Sulfate Extended Release Tablets Sales by Country (2025-2030) & (Tons)
 Table 33. Europe Morphine Sulfate Extended Release Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Morphine Sulfate Extended Release Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Morphine Sulfate Extended Release Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Morphine Sulfate Extended Release Tablets Sales by Region (2019-2024) & (Tons)
 Table 37. Asia Pacific Morphine Sulfate Extended Release Tablets Sales by Region (2025-2030) & (Tons)
 Table 38. Asia Pacific Morphine Sulfate Extended Release Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Morphine Sulfate Extended Release Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Morphine Sulfate Extended Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Morphine Sulfate Extended Release Tablets Sales by Country (2019-2024) & (Tons)
 Table 42. Latin America Morphine Sulfate Extended Release Tablets Sales by Country (2025-2030) & (Tons)
 Table 43. Latin America Morphine Sulfate Extended Release Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Morphine Sulfate Extended Release Tablets Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Morphine Sulfate Extended Release Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Morphine Sulfate Extended Release Tablets Sales by Country (2019-2024) & (Tons)
 Table 47. Middle East and Africa Morphine Sulfate Extended Release Tablets Sales by Country (2025-2030) & (Tons)
 Table 48. Middle East and Africa Morphine Sulfate Extended Release Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Morphine Sulfate Extended Release Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Morphine Sulfate Extended Release Tablets Sales (Tons) by Type (2019-2024)
 Table 51. Global Morphine Sulfate Extended Release Tablets Sales (Tons) by Type (2025-2030)
 Table 52. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2019-2024)
 Table 53. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2025-2030)
 Table 54. Global Morphine Sulfate Extended Release Tablets Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Morphine Sulfate Extended Release Tablets Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Type (2019-2024)
 Table 57. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Type (2025-2030)
 Table 58. Global Morphine Sulfate Extended Release Tablets Price (US$/Ton) by Type (2019-2024)
 Table 59. Global Morphine Sulfate Extended Release Tablets Price (US$/Ton) by Type (2025-2030)
 Table 60. Global Morphine Sulfate Extended Release Tablets Sales (Tons) by Application (2019-2024)
 Table 61. Global Morphine Sulfate Extended Release Tablets Sales (Tons) by Application (2025-2030)
 Table 62. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Application (2019-2024)
 Table 63. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Application (2025-2030)
 Table 64. Global Morphine Sulfate Extended Release Tablets Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Morphine Sulfate Extended Release Tablets Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Application (2019-2024)
 Table 67. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Application (2025-2030)
 Table 68. Global Morphine Sulfate Extended Release Tablets Price (US$/Ton) by Application (2019-2024)
 Table 69. Global Morphine Sulfate Extended Release Tablets Price (US$/Ton) by Application (2025-2030)
 Table 70. NAPP PHARMACEUTICALS LIMITED Company Information
 Table 71. NAPP PHARMACEUTICALS LIMITED Description and Business Overview
 Table 72. NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 73. NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Product
 Table 74. NAPP PHARMACEUTICALS LIMITED Recent Developments/Updates
 Table 75. Purdue Pharma Company Information
 Table 76. Purdue Pharma Description and Business Overview
 Table 77. Purdue Pharma Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 78. Purdue Pharma Morphine Sulfate Extended Release Tablets Product
 Table 79. Purdue Pharma Recent Developments/Updates
 Table 80. Mallinckrodt Pharmaceuticals Company Information
 Table 81. Mallinckrodt Pharmaceuticals Description and Business Overview
 Table 82. Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 83. Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Product
 Table 84. Mallinckrodt Pharmaceuticals Recent Developments/Updates
 Table 85. Teva Pharmaceuticals Company Information
 Table 86. Teva Pharmaceuticals Description and Business Overview
 Table 87. Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 88. Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Product
 Table 89. Teva Pharmaceuticals Recent Developments/Updates
 Table 90. Viatris Company Information
 Table 91. Viatris Description and Business Overview
 Table 92. Viatris Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 93. Viatris Morphine Sulfate Extended Release Tablets Product
 Table 94. Viatris Recent Developments/Updates
 Table 95. Allergan Company Information
 Table 96. Allergan Description and Business Overview
 Table 97. Allergan Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 98. Allergan Morphine Sulfate Extended Release Tablets Product
 Table 99. Allergan Recent Developments/Updates
 Table 100. Rhodes Pharmaceuticals Company Information
 Table 101. Rhodes Pharmaceuticals Description and Business Overview
 Table 102. Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 103. Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Product
 Table 104. Rhodes Pharmaceuticals Recent Developments/Updates
 Table 105. West-Ward Pharmaceuticals Company Information
 Table 106. West-Ward Pharmaceuticals Description and Business Overview
 Table 107. West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 108. West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Product
 Table 109. West-Ward Pharmaceuticals Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Morphine Sulfate Extended Release Tablets Distributors List
 Table 113. Morphine Sulfate Extended Release Tablets Customers List
 Table 114. Morphine Sulfate Extended Release Tablets Market Trends
 Table 115. Morphine Sulfate Extended Release Tablets Market Drivers
 Table 116. Morphine Sulfate Extended Release Tablets Market Challenges
 Table 117. Morphine Sulfate Extended Release Tablets Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Morphine Sulfate Extended Release Tablets
 Figure 2. Global Morphine Sulfate Extended Release Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Morphine Sulfate Extended Release Tablets Market Share by Type: 2023 & 2030
 Figure 4. 10mg Product Picture
 Figure 5. 30mg Product Picture
 Figure 6. 60mg Product Picture
 Figure 7. Global Morphine Sulfate Extended Release Tablets Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Morphine Sulfate Extended Release Tablets Market Share by Application: 2023 & 2030
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Others
 Figure 12. Global Morphine Sulfate Extended Release Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Morphine Sulfate Extended Release Tablets Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Morphine Sulfate Extended Release Tablets Sales (2019-2030) & (Tons)
 Figure 15. Global Morphine Sulfate Extended Release Tablets Average Price (US$/Ton) & (2019-2030)
 Figure 16. Morphine Sulfate Extended Release Tablets Report Years Considered
 Figure 17. Morphine Sulfate Extended Release Tablets Sales Share by Manufacturers in 2023
 Figure 18. Global Morphine Sulfate Extended Release Tablets Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Morphine Sulfate Extended Release Tablets Players: Market Share by Revenue in Morphine Sulfate Extended Release Tablets in 2023
 Figure 20. Morphine Sulfate Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Morphine Sulfate Extended Release Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Morphine Sulfate Extended Release Tablets Sales Market Share by Country (2019-2030)
 Figure 23. North America Morphine Sulfate Extended Release Tablets Revenue Market Share by Country (2019-2030)
 Figure 24. United States Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Morphine Sulfate Extended Release Tablets Sales Market Share by Country (2019-2030)
 Figure 27. Europe Morphine Sulfate Extended Release Tablets Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Morphine Sulfate Extended Release Tablets Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Morphine Sulfate Extended Release Tablets Revenue Market Share by Region (2019-2030)
 Figure 35. China Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Morphine Sulfate Extended Release Tablets Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Morphine Sulfate Extended Release Tablets Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Morphine Sulfate Extended Release Tablets Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Morphine Sulfate Extended Release Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Morphine Sulfate Extended Release Tablets by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Morphine Sulfate Extended Release Tablets by Type (2019-2030)
 Figure 54. Global Morphine Sulfate Extended Release Tablets Price (US$/Ton) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Morphine Sulfate Extended Release Tablets by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Morphine Sulfate Extended Release Tablets by Application (2019-2030)
 Figure 57. Global Morphine Sulfate Extended Release Tablets Price (US$/Ton) by Application (2019-2030)
 Figure 58. Morphine Sulfate Extended Release Tablets Value Chain
 Figure 59. Morphine Sulfate Extended Release Tablets Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Morphine Sulfate Injection Market Research Report 2024
Global Morphine Sulfat Market Research Report 2025
Global Doxazosin Mesylate Extended Release Tablets Market Research Report 2024
Global Hydroxychloroquine Sulfate Tablets Market Research Report 2024
Global Glucosamine Sulfate Tablets and Capsules Market Research Report 2024
Global Oxycodone Hydrochloride Extended Release Tablets Market Research Report 2024
Global Magnesium Laureth Sulfate Market Research Report 2025
Global Terbutaline Sulfate Tablets Market Research Report 2024
Global Pharmaceutical Grade Sulphate Market Research Report 2024
Global Glucosamine Sulfate Capsules Market Research Report 2024
Global High Purity Magnesium Sulfate Market Research Report 2024
Global Paromomycin Sulfate Market Research Report 2025
Global Polymyxin B Sulfate Market Research Report 2024
Global Tobramycin Sulfate Injection Market Research Report 2024
Morphine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vindesine Sulfate Market Research Report 2024
Global Vincristine sulfate Market Research Report 2024
Global Alcohol Ether Sulfate Market Research Report 2025
Global Sodium Octyl Sulfate Market Research Report 2025
Paliperidone Extended Release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions